FDA Approved: HARVONI — Supplemental Application (Gilead Sciences, Inc)

View source ↗

Summary

FDA approved a supplemental application for HARVONI (ledipasvir and sofosbuvir) to modify labeling and/or expand its indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• HARVONI (Ledipasvir and Sofosbuvir)

Snippet

SUPPL AP for HARVONI (LEDIPASVIR AND SOFOSBUVIR)